Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
J Clin Invest. 2020 Nov 2;130(11):6187. doi: 10.1172/JCI144618.
J Clin Invest. 2020.
PMID: 33044225
Free PMC article.
No abstract available.